Abstract
Objectives: The effect of magnesium sulfate on brain tissue of SD rats irradiated by 6MeV electron was investigated.
Methods: SD rats were divided into three groups: control group, irradiation (IR group) and irradiation treated with magnesium sulfate (IR+M group). After being anesthetized, the whole brains of IR group and IR+M group were exposed to 6 MeV electron radiation. IR+M group was i.p. injected with 10% magnesium sulfate (400 mg/kg) one day before radiation and three days and five days after radiation. And on the 1st, 3rd, 7th and 14th day after radiation, SD rats were euthanatized to take brain tissue for the detection of calcium, redox status and cell apoptosis, as well as the expression of NF-κB and ICAM-1.
Results: The results indicated that magnesium treatment may alleviate the elevation of calcium and enhance redox status through increasing the activities of superoxide dimutase (SOD) and myeloperodase (MPO), and decreasing the concentration of malondialdehyde (MDA). Tunnel and immunohistochemistry assay suggested that treatment with magnesium decreased the apoptosis rate of brain cells and the expressions of caspase-3, respectively. Decline of the expression of NF-κB and ICAM-1 protein was observed after the treatment of magnesium.
Conclusion: All the results demonstrated that magnesium may elicit protective effect against radiationinduced brain injury by reducing calcium overload, improving redox and inhibiting cell apoptosis. Moreover, magnesium significantly down-regulated the protein or mRNA levels of NF-κB and ICAM- 1. The findings may provide references for the application of magnesium in clinic for brain injury induced by radiation.
Keywords: Magnesium sulfate, irradiation, redox status, cell apoptosis, NF-κB/ ICAM-1, malondialdehyde (MDA).
Current Drug Delivery
Title:Protective Effects of Magnesium Sulfate on Radiation Induced Brain Injury in Rats
Volume: 15 Issue: 8
Author(s): Na Chen, Rui J. Xu, Li L. Wang, Meng Zhang, Shi C. Feng, Ju Y. Zhou and Yu Tu*
Affiliation:
- Department of Radiation Medicine, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123,China
Keywords: Magnesium sulfate, irradiation, redox status, cell apoptosis, NF-κB/ ICAM-1, malondialdehyde (MDA).
Abstract: Objectives: The effect of magnesium sulfate on brain tissue of SD rats irradiated by 6MeV electron was investigated.
Methods: SD rats were divided into three groups: control group, irradiation (IR group) and irradiation treated with magnesium sulfate (IR+M group). After being anesthetized, the whole brains of IR group and IR+M group were exposed to 6 MeV electron radiation. IR+M group was i.p. injected with 10% magnesium sulfate (400 mg/kg) one day before radiation and three days and five days after radiation. And on the 1st, 3rd, 7th and 14th day after radiation, SD rats were euthanatized to take brain tissue for the detection of calcium, redox status and cell apoptosis, as well as the expression of NF-κB and ICAM-1.
Results: The results indicated that magnesium treatment may alleviate the elevation of calcium and enhance redox status through increasing the activities of superoxide dimutase (SOD) and myeloperodase (MPO), and decreasing the concentration of malondialdehyde (MDA). Tunnel and immunohistochemistry assay suggested that treatment with magnesium decreased the apoptosis rate of brain cells and the expressions of caspase-3, respectively. Decline of the expression of NF-κB and ICAM-1 protein was observed after the treatment of magnesium.
Conclusion: All the results demonstrated that magnesium may elicit protective effect against radiationinduced brain injury by reducing calcium overload, improving redox and inhibiting cell apoptosis. Moreover, magnesium significantly down-regulated the protein or mRNA levels of NF-κB and ICAM- 1. The findings may provide references for the application of magnesium in clinic for brain injury induced by radiation.
Export Options
About this article
Cite this article as:
Chen Na , Xu J. Rui , Wang L. Li, Zhang Meng, Feng C. Shi , Zhou Y. Ju and Tu Yu*, Protective Effects of Magnesium Sulfate on Radiation Induced Brain Injury in Rats, Current Drug Delivery 2018; 15 (8) . https://dx.doi.org/10.2174/1567201815666180124112200
DOI https://dx.doi.org/10.2174/1567201815666180124112200 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nerve Injury Associated with Regional Anesthesia
Current Topics in Medicinal Chemistry The Role of Peripheral Benzodiazepine Receptors (PBRs) in CNS Pathophysiology
Current Medicinal Chemistry Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia
Current Neurovascular Research Current Phthalocyanines Delivery Systems in Photodynamic Therapy: An Updated Review
Current Medicinal Chemistry The Application of Rational Design on Phospholipase A2 Inhibitors
Current Medicinal Chemistry Comparison of the Acute Hematopoietic Capacities of Erythropoietin and U-74389G Concerning Hematocrit Levels
Cardiovascular & Hematological Disorders-Drug Targets The Development of Hyaluronic Acids Used for Skin Tissue Regeneration
Current Drug Delivery Anticancer Potential of Ginger: Mechanistic and Pharmaceutical Aspects
Current Pharmaceutical Design Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
Current Pharmaceutical Design Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
Current Neuropharmacology Pharmacodynamics and Pharmacokinetics of Antifungals for Treatment of Invasive Aspergillosis
Current Pharmaceutical Design Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) Low-dose Tissue Plasminogen Activator is as Effective as Standard Tissue Plasminogen Activator Administration for the Treatment of Acute Ischemic Stroke
Current Neurovascular Research Severe Preeclampsia
Current Women`s Health Reviews Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review
Current Pharmaceutical Biotechnology CXCR2 Receptor Antagonists: A Medicinal Chemistry Perspective
Current Topics in Medicinal Chemistry Deep Tissue Optical and Optoacoustic Molecular Imaging Technologies for Pre-Clinical Research and Drug Discovery
Current Pharmaceutical Biotechnology Role of Secretory Phospholipase A2 in CNS Inflammation: Implications in Traumatic Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Progressive Brain Damage and Alterations in Dendritic Arborization after Collagenase-Induced Intracerebral Hemorrhage in Rats
Current Neurovascular Research